Research & Development

色姐姐色姐妹色姐妹综合美国退出中导条约后 首次试射中程导弹


  “這些年大家都沒有閑著,現在我回來了,一刻都等不及想要做事,孩哥,你說我現在能干什麼?”   霍光不耐煩的道︰“這東西就是一個財富的代用品,如果有一天人們不用黃金當價值媒介了,它就是一塊無用的東西。對我們來說,土地,人,物產才是真正的財富。”色姐姐   可是,盒子被打開之後,蘭英,蘭喬就把手攥的緊緊的,渾然忘記了答應狗子的事情。色姐妹   都是很好的勤快人,唯一缺少的就是起家的資本。   狗子大笑道︰“既然沒有用,我多費口舌做什麼?”色姐妹综合   兩匹很瘦的戰馬拴在山谷口,有一口沒一口的吃著地上的青草。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo